Ambulatory Blood Pressure Monitoring: An Invaluable Tool Comes of Age for Patients with Chronic Kidney Disease
Key result
Ambulatory blood pressure monitoring was the most cost-effective strategy for diagnosing essential hypertension, producing cost-savings and gains in quality-adjusted life years for older subjects.
Why the study?
Does ambulatory blood pressure monitoring improve cost-effectiveness and QALYs compared to clinic or home BP measurements in patients screened for hypertension?
Population
Hypothetical primary-care population older than 40 years with a screening BP reading ≥140/90 mm Hg
Comparison
Ambulatory blood pressure monitoring (ABPM) vs Clinic BP measurements and home BP measurements
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Ambulatory blood pressure monitoring is highlighted as the most cost-effective strategy for diagnosing essential hypertension, leading to better treatment and reduced cardiovascular events.
Structured PICO
Does ambulatory blood pressure monitoring improve cost-effectiveness and QALYs compared to clinic or home BP measurements in patients screened for hypertension?
P
Population
Hypothetical primary-care population older than 40 years with a screening BP reading ≥140/90 mm Hg evaluated in a Markov-model analysis.
I
Intervention
Ambulatory blood pressure monitoring (ABPM)
C
Comparator
Clinic BP measurements (three separate visits) and home BP measurements
O
Outcome
Cost-effectiveness (cost-savings and quality-adjusted life years [QALYs])
Ambulatory blood pressure monitoring is highlighted as the most cost-effective strategy for diagnosing essential hypertension, leading to better treatment and reduced cardiovascular events.
Cite This Study
Sarafidis et al. (2012) conducted an editorial in Hypertension. Ambulatory blood pressure monitoring (ABPM) vs. Clinic BP measurements and home measurements was evaluated on Cost-effectiveness. Ambulatory blood pressure monitoring was the most cost-effective strategy for diagnosing essential hypertension, producing cost-savings and gains in quality-adjusted life years for older subjects.